NorthWest Biotherapeutics Inc (NWBO)

[AngeloFoca]

I would assume since we are in the middle of a controlled Phase III, switching the manufacturing technology in mid-trial is not allowed. So, as good as those results may be with the old technology, can you imagine the results with DC's that are 10X more potent? If the results we have heard of on DIRECT are any indication, I think we know the answer smile

When I spoke to Boynton 2 years ago about this matter, he said they can't change the process in the middle of the phase 3 trial, but that a comparative trial can be done - (I guess a phase 4) - once phase 3 is done.

So I expect they will keep improving it after commercialization, and I assume this also lengthens their patent runway.